A Phase III Study of Jaktinib in Adults With Moderate and Severe Atopic Dermatitis
Clinical trial NCT05526222 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05526222
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-14
- Primary completion
- 2026-06-01
- Enrollment
- 443
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.